HCV Treatment Declined Nearly Twofold Between 2015 and 2020
The COVID-19 pandemic and opioid crisis created new barriers to HCV treatment, leading to the lowest annual treatment rate in 5 years.
Hepatitis C
Regular Thyroid Screening Recommended for People With Hepatitis C
People with hepatitis C are at an increased risk for several autoimmune disorders. Researchers sought to discover a link between the virus and hypothyroidism.
Factors ID’d for Hepatitis C Infection Risk in Pregnant People in the US
County-level factors, such as higher levels of employment, modified higher individual risk.
Outcomes of a Tailored HIV Pre-Exposure Prophylaxis Service for Individuals Who Inject Drugs
Researchers conducted a study that assessed the use of an HIV pre-exposure prophylaxis service tailored to individuals who inject drugs.
Effect of Sofosbuvir-Based Antivirals on Low-Density Lipoproteins in Patients With Hepatitis C Virus
Researchers conducted a study to determine the effect of treatment with sofosbuvir-based direct-acting antivirals on changes in low-density lipoprotein concentrations among patients with hepatitis C virus infection.
Risk for Hypertriglyceridemia in Patients With HIV Infection Treated With Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy
Researchers conducted a study to determine whether integrase strand transfer inhibitor-based antiretroviral therapy is associated with lipid changes in patients with HIV infection.
Efficacy of Long-Acting Cabotegravir Plus Rilpivirine in Patients With HIV Coinfected With Asymptomatic Hepatitis C
Researchers sought to determine the safety and efficacy of treatment with long-acting cabotegravir plus rilpivirine in patients with HIV coinfected with asymptomatic hepatitis c virus.
Projected Long-Term Impact of the COVID-19 Pandemic on Outcomes Associated With Hepatitis C Virus
Researchers conducted a modeling study to determine the projected long-term impact of the COVID-19 pandemic on outcomes associated with hepatitis C virus care.
Model Evaluates HCV Elimination Forecast Among People Who Inject Drugs
Based on a mathematical model, investigators evaluated improvements to the care cascade for people with hepatitis C virus who inject drugs.
Outcomes of Rapid Treatment With Sofosbuvir-Velpatasvir in Patients With Hepatitis C Virus who use Injectable Drugs
Researchers conducted a study that compared rapid treatment with a 7-day course of sofosbuvir-velpatasvir with usual compare in patients with hepatitis C virus infection who use injectable drugs.
- Loading...
Loading...
Next post in ID Week 2021
Loading... 
Loading...